Literature DB >> 18486262

Molecular targeted therapies in hepatocellular carcinoma: from pre-clinical models to clinical trials.

Pippa Newell, Augusto Villanueva, Josep M Llovet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18486262     DOI： 10.1016/j.jhep.2008.04.006

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  13 in total

1.  Ceramide production mediates cinobufotalin-induced growth inhibition and apoptosis in cultured hepatocellular carcinoma cells.

Authors:  Long Cheng; Yuan-Zheng Chen; Yi Peng; Nan Yi; Xin-Shi Gu; Yong Jin; Xu-Ming Bai
Journal:  Tumour Biol       Date:  2015-02-28

2.  Dieckol, isolated from Ecklonia stolonifera, induces apoptosis in human hepatocellular carcinoma Hep3B cells.

Authors:  Jin-Soo Yoon; Anandam Kasin Yadunandam; Soon-Jin Kim; Hee-Chul Woo; Hyeung-Rak Kim; Gun-Do Kim
Journal:  J Nat Med       Date:  2012-10-09       Impact factor: 2.343

3.  The efficacy of combination therapy using adeno-associated virus-mediated co-expression of apoptin and interleukin-24 on hepatocellular carcinoma.

Authors:  Lijie Yuan; Hengyu Zhao; Liqiu Zhang; Xinghan Liu
Journal:  Tumour Biol       Date:  2013-08-02

4.  miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression.

Authors:  Wenjing Mu; Chaobo Hu; Haibin Zhang; Zengqiang Qu; Jin Cen; Zhixin Qiu; Chao Li; Haozhen Ren; Yixue Li; Xianghuo He; Xiaolei Shi; Lijian Hui
Journal:  Cell Res       Date:  2015-02-20       Impact factor: 25.617

Review 5.  Hepatocellular carcinoma: insight from animal models.

Authors:  Yan Li; Zhao-You Tang; Jin-Xuan Hou
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-25       Impact factor: 46.802

6.  Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25).

Authors:  Roniel Cabrera; Miguel Ararat; Mengde Cao; Yiling Xu; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 7.  Targeted therapy for hepatocellular carcinoma.

Authors:  Hans Christian Spangenberg; Robert Thimme; Hubert E Blum
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-06-02       Impact factor: 46.802

Review 8.  MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

Authors:  E Callegari; L Gramantieri; M Domenicali; L D'Abundo; S Sabbioni; M Negrini
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

Review 9.  MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.

Authors:  Ulrich H Weidle; Daniela Schmid; Fabian Birzele; Ulrich Brinkmann
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

10.  Gadoxetate acid-enhanced MRI of hepatocellular carcinoma in a c-myc/TGFα transgenic mouse model including signal intensity and fat content: initial experience.

Authors:  Huedayi Korkusuz; Lea Knau; Wolfgang Kromen; Frank Huebner; Renate Hammerstingl; Sebastian Lindemayr; Verena Bihrer; Albrecht Piiper; Thomas J Vogl
Journal:  Cancer Imaging       Date:  2012-03-07       Impact factor: 3.909
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.